Loading...
10x Genomics, Inc.
TXG•NASDAQ
Healthcare
Medical - Healthcare Information Services
$14.11
$0.38(2.77%)
10x Genomics, Inc. (TXG) Financial Performance & Income Statement Overview
Review 10x Genomics, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-1.28%
↓ 1.28%
Operating Income Growth
0.20%
↑ 0.20%
Net Income Growth
28.41%
↑ 28.41%
Operating Cash Flow Growth
143.85%
↑ 143.85%
Operating Margin
-27.60%
↓ 27.60%
Gross Margin
68.79%
↑ 68.79%
Net Profit Margin
-25.14%
↓ 25.14%
ROE
-21.93%
↓ 21.93%
ROIC
-21.67%
↓ 21.67%
10x Genomics, Inc. (TXG) Income Statement & Financial Overview
Review 10x Genomics, Inc.'s (TXG) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $165.02M | $151.65M | $153.10M | $141.006M |
| Cost of Revenue | $54.07M | $45.26M | $46.21M | $45.44M |
| Gross Profit | $110.95M | $106.39M | $106.90M | $95.57M |
| Gross Profit Ratio | $0.67 | $0.70 | $0.70 | $0.68 |
| R&D Expenses | $66.97M | $66.17M | $62.92M | $67.94M |
| SG&A Expenses | $93.83M | $81.70M | $83.04M | $84.67M |
| Operating Expenses | $160.79M | $147.88M | $148.63M | $154.97M |
| Total Costs & Expenses | $214.86M | $193.14M | $194.84M | $200.40M |
| Interest Income | $4.03M | $4.97M | $4.71M | $4.74M |
| Interest Expense | $0.00 | $2000.00 | $1000.00 | $1000.00 |
| Depreciation & Amortization | $10.56M | $10.75M | $10.90M | $11.49M |
| EBITDA | -$37.82M | -$23.69M | -$26.18M | -$46.31M |
| EBITDA Ratio | -$0.23 | -$0.16 | -$0.17 | -$0.33 |
| Operating Income | -$49.84M | -$41.48M | -$41.74M | -$59.40M |
| Operating Income Ratio | -$0.30 | -$0.27 | -$0.27 | -$0.42 |
| Other Income/Expenses (Net) | $1.46M | $7.05M | $4.66M | $1.59M |
| Income Before Tax | -$48.38M | -$34.44M | -$37.08M | -$57.80M |
| Income Before Tax Ratio | -$0.29 | -$0.23 | -$0.24 | -$0.41 |
| Income Tax Expense | $648000.00 | $1.31M | $818000.00 | $2.15M |
| Net Income | -$49.03M | -$35.75M | -$37.90M | -$59.95M |
| Net Income Ratio | -$0.30 | -$0.24 | -$0.25 | -$0.43 |
| EPS | -$0.41 | -$0.30 | -$0.32 | -$0.50 |
| Diluted EPS | -$0.41 | -$0.30 | -$0.32 | -$0.50 |
| Weighted Avg Shares Outstanding | $121.60M | $120.73M | $120.07M | $119.39M |
| Weighted Avg Shares Outstanding (Diluted) | $121.60M | $120.73M | $120.07M | $119.39M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan